arrow
N

Nilson Nicolau-Júnior

universidade federal de uberlândia
H指数:11
被引数:319

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

4-Nerolidylcatechol binds to Derlin-1 and modulates endoplasmic reticulum stress markers of androgen-independent prostate cancer cells.

4-橙花叔醇儿茶酚与Derlin-1结合并调节雄激素非依赖性前列腺癌细胞内质网应激标志物。

2026-09-290
OAAI
Microencapsulation of Annona crassiflora extract using maltodextrin: Material design and evaluation of antioxidant, antiglycation, and antiaging properties in vitro and in silico

利用麦芽糊精对Annona crassiflora提取物的微胶囊化:材料设计与体外及计算机模拟中抗氧化、抗糖化及抗衰老性能的评估

2025-10-070
OAAI
Green synthesis of silver nanoparticles using Pyrostegia venusta extract, characterization and estimation of antioxidant, antiglycation and anti-aging activities

使用Pyrostegia venusta提取物绿色合成银纳米颗粒及其抗氧化、抗糖化、抗衰老活性的表征与评估

2025-07-250
PREAI
A Structural In Silico Analysis of Novel Epitopes from Toxoplasma gondii Proteins for the Serodiagnosis of Toxoplasmosis

利用Toxoplasma gondii蛋白的新型表位进行弓形体病血清学诊断的结构体外分析

2025-05-140
OA
Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro

山达胶酸是SARS-CoV-2 RNA合成、病毒体组装和释放的强效抑制剂(体外研究)。

2025-05-090
OA
Green biosynthesis of silver nanoparticles using anthocyanins-rich extract from Euterpe edulis fruits (AnthocyanOx®): Assessment in vitro of antioxidant and antiglycation activities, and in silico anti-aging activity
2025-05-010
PRE
Antioxidant, antitumoral, antimetastatic effect and inhibition of collagenase enzyme activity of Eleutherine bulbosa (Dayak onion) extract: In vitro, in vivo and in silico approaches (vol 318, 117005, 2024)

抗氧化、抗肿瘤、抗转移效应以及Eleutherine bulbosa (Dayak onion)提取物的胶原酶酶活性抑制作用:体外、体内和计算机模拟方法(卷318,117005,2024)

2025-04-010
PRE
Green synthesis of silver nanoparticles using food supplement from Avena sativa L., and their antioxidant, antiglycation, and anti-aging activities: In vitro and in silico studies
2024-09-012
PRE
Insights on the SARS- CoV-2 genome variability: the lesson learned in Brazil and its impacts on the future of pandemics

关于传染性非典型肺炎CoV-2基因组变异性的见解: 巴西的经验教训及其对流行病未来的影响

2021-11-304
OAAI